Stock & Company Details
Elicio Therapeutics Inc. $ELTX
Price:
N/A
N/A
26M
$48M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.75
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ELTX technical indicators
Latest Elicio Therapeutics Inc. (ELTX) indicator readings as of 2026-10-09.
ELTX's 14-day RSI is 35.8, in neutral territory. At $1.89 it is trading 73.9% below its 200-day moving average of $7.25, and below its 50-day average of $2.46. Price sits in the middle of its Bollinger Bands ($1.77 to $1.99). ADX reads 34.3, indicating a trending market.
Overview
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers.
Finance Bot
Ask your questions
Start by typing a question below.
